Research programme: apoptosis inducers - Gemin X

Drug Profile

Research programme: apoptosis inducers - Gemin X

Alternative Names: GX 14; p53 Independent Mechanism - Gemin X

Latest Information Update: 27 May 2011

Price : $50

At a glance

  • Originator Gemin X Biotechnologies
  • Class Diterpenes; Small molecules
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 10 Apr 2008 Research phase in Cancer in Canada (unspecified route)
  • 12 Mar 2003 Preclinical data from a media release have been added to the Cancer pharmacodynamics section
  • 06 Nov 2002 Preclinical trials in Cancer in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top